HRTS 股價展望與 ETF 分析 - 配息·管理費·持股·NAV·RSI·MACD

HRTS

Tema Heart & Health ETF

收盤價 10月16日 4:00 PM ET（韓國 10/17 05:00）

$36.90

-0.33 ▼ -0.88%

10月16日 4:00 PM ET（韓國 10/17 05:00）

$36.90

+0.00 +0.00%

上升通道阻力線 39.29 支撐線 35.25 維持連續5天同一條線由 AI 繪製的參考線，可能有誤，僅供參考，並非預測。

詳細指標表

Category ⓘ	Global or ExUS Equities - Industry Sector	Expense ⓘ	0.75%	Return% 1Y ⓘ	17.39%	Total Holdings ⓘ	46	Perf Week ⓘ	1.89%	Volume ⓘ	2,359
Asset Type ⓘ	Equities (Stocks)	AUM ⓘ	$55M	Return% 3Y ⓘ	-	NAV ⓘ	$37.23	Perf Month ⓘ	1.17%	Avg Volume ⓘ	0.00M
ETF Type ⓘ	Global Equities	Dividend TTM ⓘ	$0.47 (1.28%)	Return% 5Y ⓘ	-	52W High ⓘ	-5.05%	Perf Quarter ⓘ	2.78%	Rel Volume ⓘ	0.62
Active/Passive ⓘ	Active	Div Gr. 3/5Y ⓘ	-	Return% 10Y ⓘ	-	52W Low ⓘ	15.5%	Perf Half Y ⓘ	6.54%	Prev Close ⓘ	$37.23
IPO ⓘ	2023/11/21	Flows% 1M ⓘ	-0.65%	Return% SI ⓘ	13.35%	RSI (14) ⓘ	55.28	Perf YTD ⓘ	4.57%	Price ⓘ	$36.90
Beta ⓘ	0.65	Flows% 3M ⓘ	-0.65%	Flows% YTD ⓘ	-4.35%	Flows% 1Y ⓘ	-5.15%	Perf Year ⓘ	14.76%	Volatility(W/M) ⓘ	0.65% 0.74%
SMA20 ⓘ	1.85%	SMA50 ⓘ	-0.1%	SMA200 ⓘ	4.1%	ATR ⓘ	0.46

ETF 簡介

Tema Heart & Health ETFHRTS | NASD | 主動管理型查看深度分析

Tema Cardiovascular and Metabolic ETF seeks to provide long-term growth of capital. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund advisor generally is expected to consist of more than 15 companies but not more than 100 companies. The fund is non-diversified.

HRTS ETF 一覽

0.75% 越低越好

$55M 管理資產

46檔

1.28%

掛牌日 2023年

管理方式主動管理

發行公司 Tema

主要持有標的持有 46 檔

前 10 大持股占 基金的 49%